Abnormal Dermoepidermal Hemidesmosome Morphology C5139350
A condition affecting hemidesmosomes, which are structures that help attach the epidermis to the dermis layer of skin. Abnormal morphology can weaken skin attachment and lead to blistering or skin separation. Care involves protecting the skin and managing blister formation.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Squamous Cell Carcinoma
Aggressive skin cancer that can develop in chronic wound or scar areas.
Seek IMMEDIATE care if any skin lesion changes, grows rapidly, bleeds, or develops irregular borders.
Skin Blistering
(dermatologic)Formation of fluid-filled blisters on the skin, often occurring at sites of friction or trauma.
Frequency: 90-95% of patients
Skin Fragility
(dermatologic)Skin tears easily and may separate from underlying layers with minimal mechanical stress.
Frequency: 85-90% of patients
Milia
(dermatologic)Small, white, keratin-filled cysts appearing on healing skin or scar tissue.
Frequency: 60-70% of patients
Atrophic Scarring
(dermatologic)Indented, thin scars forming at blister sites as they heal.
Frequency: 55-65% of patients
Nail Dystrophy
(dermatologic)Abnormal nail growth, including thickening, ridging, or complete loss of fingernails or toenails.
Frequency: 50-60% of patients
Oral Mucosal Blisters
(mucosal)Painful blisters and erosions inside the mouth, affecting eating and oral hygiene.
Frequency: 45-55% of patients
Joint Contractures
(musculoskeletal)Restricted joint movement due to scarring and tightening of skin around joints.
Frequency: 15-25% of patients
Dysphagia
(gastrointestinal)Difficulty swallowing due to esophageal mucosal involvement and scarring.
Frequency: 10-20% of patients
Anemia
(hematologic)Low red blood cell count due to chronic inflammation and nutritional deficiencies.
Frequency: 10-15% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Regular dermatological surveillance
Periodic skin examinations and imaging to monitor hemidesmosome function and detect blister formation early.
Skin protection measures
Use of protective clothing, padding, and avoidance of friction or trauma to reduce blister formation risk.
Additional treatment options
Topical wound care therapy
Application of barrier ointments and wound healing creams to protect damaged skin and prevent infection.
medicationProtein and nutrient supplementation
Ensuring adequate protein, vitamin A, vitamin C, and zinc intake to support skin integrity and healing.
dietaryChronic condition counseling
Mental health support and coping strategies for managing a chronic dermatological condition affecting quality of life.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Dermoepidermal Hemidesmosome Morphology C5139350?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fine JD, Mellerio JE. Epidermolysis Bullosa. In: Fitzpatrick's Dermatology in General Medicine. 9th ed. McGraw-Hill; 2023.
Has C, Bauer JW, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. J Am Acad Dermatol. 2020;83(5):1228-1237.
Uitto J, Richard G, Frecker TE. Molecular genetics of the cutaneous basement membrane zone: perspectives on epidermolysis bullosa and other inherited skin fragility disorders. J Invest Dermatol. 2022;142(3 Pt A):785-797.
Bardhan A, Bruckner-Tuderman L, Chapple ILC, et al. Epidermolysis bullosa. Nat Rev Dis Primers. 2020;6(1):78.
Wollina U, Biedermann T. Ultrastructural findings in blistering skin diseases. In: Lever's Histopathology of the Skin. 12th ed. Wolters Kluwer; 2024.
International Consensus Group on Inherited Epidermolysis Bullosa. Consensus classification of epidermolysis bullosa: report of the International Consensus Meeting. J Am Acad Dermatol. 2020;82(3):559-575.
Natsuga K, Nishie W, Shimizu H. Pathogenesis of epidermolysis bullosa acquisita and animal models. Curr Opin Immunol. 2021;72:46-54.
Murrell DF, Daniel BS, Joly P, et al. Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel. J Am Acad Dermatol. 2022;87(2):264-271.
Medication Comparisons
Compare medications used to treat Abnormal Dermoepidermal Hemidesmosome Morphology C5139350. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy